Published in Biomaterials on October 21, 2005
Fibrin hydrogels for non-viral vector delivery in vitro. J Control Release (2009) 1.63
Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.47
Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem (2008) 1.43
Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials (2009) 1.05
Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials (2008) 1.04
Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics (2014) 1.02
Lentivirus delivery by adsorption to tissue engineering scaffolds. J Biomed Mater Res A (2010) 0.95
Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst (2005) 0.94
Optimization of PAMAM-gold nanoparticle conjugation for gene therapy. Biomaterials (2013) 0.90
Nanoparticulate systems for polynucleotide delivery. Int J Nanomedicine (2007) 0.87
Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure--activity relationships highlight the role of charge distribution across dendrimer generations. ACS Nano (2013) 0.81
The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation. J Nanopart Res (2013) 0.80
Peptide-mediated lipofection is governed by lipoplex physical properties and the density of surface-displayed amines. J Pharm Sci (2008) 0.79
Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells. Front Pharmacol (2017) 0.75
New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery. Nanomedicine (Lond) (2016) 0.75
A mechanistic investigation exploring the differential transfection efficiencies between the easy-to-transfect SK-BR3 and difficult-to-transfect CT26 cell lines. J Nanobiotechnology (2017) 0.75
Local application of BMP-2 specific plasmids in fibrin glue does not promote implant fixation. BMC Musculoskelet Disord (2011) 0.75
Fabrication of functionalized double-lamellar multifunctional envelope-type nanodevices using a microfluidic chip with a chaotic mixer array. PLoS One (2012) 0.75
Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers. J Control Release (2016) 0.75
Evaluation of Chitosan-Tripolyphosphate Nanoparticles as a p-shRNA Delivery Vector: Formulation, Optimization and Cellular Uptake Study. J Nanopharm Drug Deliv (2013) 0.75
Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature (2005) 19.15
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Microarrays of cells expressing defined cDNAs. Nature (2001) 5.05
PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther (1999) 2.90
Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 2.83
Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med (2005) 2.71
Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng (2000) 2.49
Harmful potential of viral vectors fuels doubts over gene therapy. Nature (2003) 2.39
Multilayered thin films that sustain the release of functional DNA under physiological conditions. Langmuir (2004) 2.23
Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther (2005) 1.87
Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater (2005) 1.83
Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc (2003) 1.81
Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther (2005) 1.62
Controlled release systems for DNA delivery. Mol Ther (2004) 1.59
Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther (2005) 1.56
Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry (1997) 1.56
Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification. J Control Release (2003) 1.54
A novel transfecting peptide comprising a tetrameric nuclear localization sequence. J Mol Med (Berl) (2003) 1.48
DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release (1998) 1.46
Cationic lipid-DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways. Expert Opin Biol Ther (2005) 1.45
Nuclear entry of nonviral vectors. Gene Ther (2005) 1.40
Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol (2004) 1.36
Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. J Am Chem Soc (2005) 1.34
DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials (2005) 1.34
Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. J Gene Med (2003) 1.30
Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther (1997) 1.30
Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci (2005) 1.27
Gene transfer with modified polyethylenimines. J Gene Med (2004) 1.26
High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization. Biotechnol Prog (2001) 1.20
New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. J Am Chem Soc (2004) 1.19
Structural effects of carbohydrate-containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centers. Bioconjug Chem (2003) 1.17
Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther (2005) 1.15
Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J Gene Med (2002) 1.15
Translocating peptides and proteins and their use for gene delivery. Curr Opin Biotechnol (2000) 1.14
Substrate-mediated delivery from self-assembled monolayers: effect of surface ionization, hydrophilicity, and patterning. Acta Biomater (2005) 1.14
Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjug Chem (2004) 1.10
Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug Chem (2001) 1.10
Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. Annu Rev Biomed Eng (2004) 1.07
Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther (2002) 1.07
Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol (1999) 1.05
Cationic corticosteroid for nonviral gene delivery. Gene Ther (2004) 0.99
Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes. Biophys J (2004) 0.98
Physicochemical optimisation of plasmid delivery by cationic lipids. J Gene Med (2004) 0.93
Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther (2001) 0.91
Structural effects of carbohydrate-containing polycations on gene delivery. 3. Cyclodextrin type and functionalization. Bioconjug Chem (2003) 0.90
The in vivo use of chloroquine to promote non-viral gene delivery to the liver via the portal vein and bile duct. J Gene Med (2003) 0.89
Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J Control Release (2004) 0.88
Novel cationic pentablock copolymers as non-viral vectors for gene therapy. J Control Release (2004) 0.86
Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J Control Release (2005) 0.84
Influence of membrane-active peptides on lipospermine/DNA complex mediated gene transfer. Bioconjug Chem (1997) 0.83
Lysosome-disrupting peptide increases the efficiency of in-vivo gene transfer by liposome-encapsulated DNA. J Drug Target (1998) 0.78
Transfection with fluorinated lipoplexes based on new fluorinated cationic lipids and in the presence of a bile salt surfactant. Bioconjug Chem (2004) 0.77
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol (2012) 3.11
Cancer survivors and infertility: a review of a new problem and novel answers. J Support Oncol (2006) 3.01
Tissue-engineered follicles produce live, fertile offspring. Tissue Eng (2006) 2.87
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06
Postnatal regulation of germ cells by activin: the establishment of the initial follicle pool. Dev Biol (2006) 1.85
Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol Reprod (2006) 1.83
In vitro grown human ovarian follicles from cancer patients support oocyte growth. Hum Reprod (2009) 1.71
Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug Chem (2002) 1.70
Regulation of mouse follicle development by follicle-stimulating hormone in a three-dimensional in vitro culture system is dependent on follicle stage and dose. Biol Reprod (2005) 1.67
Physical properties of alginate hydrogels and their effects on in vitro follicle development. Biomaterials (2007) 1.66
The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials (2005) 1.63
Fibrin hydrogels for non-viral vector delivery in vitro. J Control Release (2009) 1.63
Encapsulated three-dimensional culture supports development of nonhuman primate secondary follicles. Biol Reprod (2009) 1.62
Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol Ther (2005) 1.62
Novel approach for the three-dimensional culture of granulosa cell-oocyte complexes. Tissue Eng (2003) 1.60
Controlled release systems for DNA delivery. Mol Ther (2004) 1.59
Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification. J Control Release (2003) 1.54
Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng (2005) 1.50
Fate of the initial follicle pool: empirical and mathematical evidence supporting its sufficiency for adult fertility. Dev Biol (2006) 1.49
Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.47
Interpenetrating fibrin-alginate matrices for in vitro ovarian follicle development. Biomaterials (2009) 1.46
DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials (2005) 1.34
Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation (2008) 1.27
Secondary follicle growth and oocyte maturation by culture in alginate hydrogel following cryopreservation of the ovary or individual follicles. Biotechnol Bioeng (2009) 1.27
Engineering the follicle microenvironment. Semin Reprod Med (2007) 1.24
Chromosome cohesion decreases in human eggs with advanced maternal age. Aging Cell (2012) 1.24
Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation (2006) 1.23
Gene expression and internalization following vector adsorption to immobilized proteins: dependence on protein identity and density. J Gene Med (2007) 1.23
The mouse follicle microenvironment regulates antrum formation and steroid production: alterations in gene expression profiles. Biol Reprod (2008) 1.23
Controllable delivery of non-viral DNA from porous scaffolds. J Control Release (2003) 1.21
In vitro oocyte maturation and preantral follicle culture from the luteal-phase baboon ovary produce mature oocytes. Biol Reprod (2010) 1.20
Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials (2005) 1.20
Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J Biomed Mater Res A (2006) 1.20
Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab (2012) 1.19
Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices (2004) 1.17
Neurotrophin releasing single and multiple lumen nerve conduits. J Control Release (2005) 1.17
Non-viral vector delivery from PEG-hyaluronic acid hydrogels. J Control Release (2007) 1.17
A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano (2014) 1.16
A novel two-step strategy for in vitro culture of early-stage ovarian follicles in the mouse. Fertil Steril (2009) 1.15
Substrate-mediated delivery from self-assembled monolayers: effect of surface ionization, hydrophilicity, and patterning. Acta Biomater (2005) 1.14
Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials (2011) 1.13
Tissue engineering tools for modulation of the immune response. Biotechniques (2011) 1.12
A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health. J Assist Reprod Genet (2010) 1.12
Distribution of extracellular matrix proteins type I collagen, type IV collagen, fibronectin, and laminin in mouse folliculogenesis. Histochem Cell Biol (2006) 1.10
The role of the extracellular matrix in ovarian follicle development. Reprod Sci (2007) 1.09
Engineering biomaterial systems to enhance viral vector gene delivery. Mol Ther (2011) 1.07
Extracellular matrix functions in follicle maturation. Semin Reprod Med (2006) 1.07
Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials (2009) 1.05
Preserving female fertility following cancer treatment: current options and future possibilities. Pediatr Blood Cancer (2009) 1.04
Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials (2008) 1.04
Patterned PLG substrates for localized DNA delivery and directed neurite extension. Biomaterials (2007) 1.04
Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair Regen (2007) 1.03
Murine granulosa cell morphology and function are regulated by a synthetic Arg-Gly-Asp matrix. Mol Cell Endocrinol (2003) 1.03
Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther (2008) 1.03
Hydrogel network design using multifunctional macromers to coordinate tissue maturation in ovarian follicle culture. Biomaterials (2011) 1.03
Spatially patterned gene delivery for localized neuron survival and neurite extension. Mol Ther (2007) 1.02
Multiple channel bridges for spinal cord injury: cellular characterization of host response. Tissue Eng Part A (2009) 1.02
Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice. Tissue Eng Part A (2011) 1.02
Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J Control Release (2011) 1.01
Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Lab Invest (2008) 1.01
Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia. Tissue Eng Part A (2013) 1.01
Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials (2011) 1.00
Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface. Exp Neurol (2004) 0.99
Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials (2010) 0.98
Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther (2010) 0.98
Drug-releasing scaffolds fabricated from drug-loaded microspheres. J Biomed Mater Res (2002) 0.97
Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma. Mol Cancer Res (2010) 0.97
Dynamic, large-scale profiling of transcription factor activity from live cells in 3D culture. PLoS One (2010) 0.97
Lentivirus delivery by adsorption to tissue engineering scaffolds. J Biomed Mater Res A (2010) 0.95
Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels. J Control Release (2010) 0.95
Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion. Int J Cancer (2009) 0.95
Future Directions in Oncofertility and Fertility Preservation: A Report from the 2011 Oncofertility Consortium Conference. J Adolesc Young Adult Oncol (2013) 0.95
Bioluminescence imaging for assessment and normalization in transfected cell arrays. Biotechnol Bioeng (2007) 0.94
Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst (2005) 0.94
Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression. J Control Release (2006) 0.93
Efficacy of immobilized polyplexes and lipoplexes for substrate-mediated gene delivery. Biotechnol Bioeng (2009) 0.93
Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein. J Biol Chem (2012) 0.93
The impact of adhesion peptides within hydrogels on the phenotype and signaling of normal and cancerous mammary epithelial cells. Biomaterials (2012) 0.93
Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models. Biomaterials (2011) 0.91
Spatially patterned gene expression for guided neurite extension. J Neurosci Res (2009) 0.91
The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. Biomaterials (2009) 0.90
Surface polyethylene glycol enhances substrate-mediated gene delivery by nonspecifically immobilized complexes. Acta Biomater (2007) 0.90
Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion. Cancer (2008) 0.89
Gene expression in mouse ovarian follicle development in vivo versus an ex vivo alginate culture system. Reproduction (2011) 0.89
Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis. Biomaterials (2012) 0.89
Embryonic fibroblasts enable the culture of primary ovarian follicles within alginate hydrogels. Tissue Eng Part A (2012) 0.89
Primate follicular development and oocyte maturation in vitro. Adv Exp Med Biol (2013) 0.89
Gene Delivery by Immobilization to Cell-Adhesive Substrates. MRS Bull (2005) 0.89
Alginate encapsulation supports the growth and differentiation of human primordial follicles within ovarian cortical tissue. J Assist Reprod Genet (2014) 0.88
Bioengineering and the ovarian follicle. Cancer Treat Res (2007) 0.88
Cellular arrays for large-scale analysis of transcription factor activity. Biotechnol Bioeng (2011) 0.88
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo. PLoS One (2013) 0.88
Noninvasive index of cryorecovery and growth potential for human follicles in vitro. Biol Reprod (2010) 0.88
Channel density and porosity of degradable bridging scaffolds on axon growth after spinal injury. Biomaterials (2013) 0.87
Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds. Drug Deliv Transl Res (2011) 0.87
Dynamic transcription factor networks in epithelial-mesenchymal transition in breast cancer models. PLoS One (2013) 0.87
Hypoxia-mediated carbohydrate metabolism and transport promote early-stage murine follicle growth and survival. Am J Physiol Endocrinol Metab (2014) 0.86
Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A (2011) 0.86
A method for ovarian follicle encapsulation and culture in a proteolytically degradable 3 dimensional system. J Vis Exp (2011) 0.86
Non-viral gene delivery transfection profiles influence neuronal architecture in an in vitro co-culture model. Biotechnol Bioeng (2009) 0.86